Apria Healthcare Group Inc. Names John G. Figueroa to Succeed Retiring Executive Chairman and Chief Executive Officer Norman C.

Apria Healthcare Group Inc. Names John G. Figueroa to Succeed Retiring
Executive Chairman and Chief Executive Officer Norman C. Payson, MD

LAKE FOREST, Calif., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Apria Healthcare Group
Inc., one of the nation's leading home healthcare companies, today announced
that John G. Figueroa has been appointed Chief Executive Officer (CEO) and
Chairman of the Company's Board of Directors, succeeding Norman C. Payson, MD,
who has announced his intention to retire from those positions. Dr. Payson
will remain on Apria's Board of Directors and serve as a senior advisor to the
Company. Mr. Figueroa will relocate to Denver, Colorado, where he will also
assume the position of CEO for the Company's home infusion business unit,
Coram LLC. Daniel E. Greenleaf, who has served as Coram's President since 2008
and as its CEO for the past eight months, is leaving the organization to
pursue other opportunities. The above changes are effective immediately.
Daniel J. Starck will continue to lead the Company's respiratory therapy/home
medical equipment business as CEO of the Apria Healthcare, Inc. business unit.

Mr. Figueroa most recently served as CEO and Board Member of Cincinnati,
Ohio-based Omnicare, Inc., a Fortune 500 healthcare services company providing
pharmaceuticals and related services to long-term care facilities and
specialized drugs for complex disease states.Prior to joining Omnicare, Mr.
Figueroa served as President of McKesson Corporation's U.S. Pharmaceutical
Group from 2006-2010 after holdingprogressively more responsible operations
and sales positions in the company's Supply Solutions, Pharmaceutical and
Health Systems groups from 1997 through early 2006.He spent the initial years
of his career in various sales and operations roles for Baxter Healthcare
Corporation's Hospitex and Medical Surgical divisions.

A 1986 graduate of the University of California at Los Angeles with a B.A. in
English and a B.A. in Political Science, Mr. Figueroa also holds a Master of
Business Administration degree from Pepperdine University in Malibu,
California, where he was honored as a Distinguished Alumnus in 2009.From 1985
through 1990, he served as a Commissioned Officer in the United States Army.

Dr. Payson became Apria's CEO and Executive Chairman in December 2008 after
The Blackstone Group (NYSE: BX) purchased the Company in October of that
year.Prior to Blackstone's acquisition he served as a member of the Apria
Board of Directors since 2006.Dr. Payson has had a 30-year career as CEO of
multiple healthcare organizations, including two S&P 500 publicly-traded
companies. He has worked closely with private equity firms in the
transformation of several publicly-traded and privately-held healthcare
companies.Dr. Payson has also been very active in healthcare philanthropy and
post-doctoral education.

Blackstone Senior Managing Director and Apria Board Member Neil Simpkins said,
"On behalf of the entire Blackstone organization and 14,000 Apria Healthcare
employees nationwide, I want to thank Dr. Payson for his leadership of and
myriad contributions to the Company over the past four years.He led Apria
through one of the most challenging periods in the history of the home
healthcare industry, as both government and non-government payors adopted new
models of contracting and care.The Company benefited greatly from his
extensive experience in managing healthcare organizations in periods of change
and his industry-leading expertise in managed care. As he has agreed to
continue providing the Company with his counsel as senior advisor and as an
ongoing, active member of Apria's Board, we expect a smooth transition to John
Figueroa's leadership. We also appreciate Dan Greenleaf's services in leading
the Coram infusion business unit and we wish him well in his future
endeavors."

Regarding Mr. Figueroa's appointment, Mr. Simpkins added, "John brings
extensive experience in leading public companies or large business units of
multi-billion dollar companies in the healthcare services industry –
experience that complements the Coram business very well.His proven track
record includes driving sales and operations initiatives which lead to
enhanced patient care services, revenue growth and operating performance.I am
confident that John's leadership will enable Apria Healthcare Group and Coram
to succeed in an increasingly complex and competitive national homecare
market."

Dr. Payson commented, "It has been a privilege to serve Apria for four years
as CEO.As I've traveled the country, I've witnessed first-hand the quality
patient care and service that our employees provide to tens of thousands of
patients every day.I am very pleased with our recruitment of John Figueroa as
CEO. I look forward to continuing to serve as senior advisor and on the Board,
and now to spending more time in philanthropy, as well as teaching the next
generation of physicians and other healthcare leaders."

About Apria Healthcare Group Inc.

Apria provides home infusion therapy, home respiratory therapy and home
medical equipment through approximately 550 locations serving patients in all
50 states.With over $2.3 billion in annual net revenues, Apria is one of the
nation's leading home healthcare companies. For more information, visit
www.apria.com or www.coramhc.com.

About The Blackstone Group

Blackstone (NYSE: BX) is one of the world's leading investment and advisory
firms. Blackstone seeks to create positive economic impact and long-term value
for its investors, the companies it invests in, the companies it advises and
the broader global economy. The firm accomplishes this through the commitment
of its extraordinary people and flexible capital. Blackstone's alternative
asset management businesses include the management of corporate private equity
funds, real estate funds, hedge funds, funds of funds, debt funds,
collateralized loan obligation vehicles (CLOs) and closed-end mutual funds.
The Blackstone Group also provides various financial advisory services,
including mergers and acquisitions advisory, restructuring and reorganization
advisory and fund placement services. Further information is available at
www.blackstone.com.

CONTACT: Chris Karkenny
         Chief Financial Officer
         949.639.4990
        
         Lisa M. Getson
         Executive Vice President
         949.639-2021
 
Press spacebar to pause and continue. Press esc to stop.